Company / Operating Cash Flow per Share
enGene Holdings Inc. Operating Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.94
FY2025
5-year range
-$35.72 / -$1.28
FY2022-FY2025
Trend
-51.9%
vs FY2024
Sector context
#145 of 208
Health Care
What the data says
At $-1.94, enGene Holdings Inc.'s operating cash flow per share ranks #145 of 208 in the Health Care sector. Improved from $-35.72 to $-1.94 over the past 2 years.
Based on SEC 10-K filings.
-1.94 in FY2025.
Improved from $-35.72 to $-1.94 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#145 of 208 in Health CareTop 70% of 208This company -$1.94 Sector average -$21.21
▼
+90.8% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 51.9% year-over-year.
- Ranks #145 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.94 | -51.9% |
| FY2024 | -$1.28 | +96.4% |
| FY2023 | -$35.72 | -33.0% |
| FY2022 | -$26.85 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026